• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Guardant Health Inc (NQ: GH )

    23.49 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 23.49
    Bid (Size) 23.70 (3)
    Ask (Size) 24.86 (3)
    Prev. Close 23.49
    Today's Range 23.49 - 23.49
    52wk Range 15.81 - 37.04
    Shares Outstanding 101,298,669
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long
    From Guardant Health, Inc.
    Via Business Wire
    Sky Harbour Group, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga

    Performance

    YTD
    -11.39%
    -11.39%
    1 Month
    -12.15%
    -12.15%
    3 Month
    -19.25%
    -19.25%
    6 Month
    +37.13%
    +37.13%
    1 Year
    -10.55%
    -10.55%

    More News

    Read More
    iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Key Takeaways From Guardant Health Analyst Ratings
    Via Benzinga
    Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types
    From Guardant Health, Inc.
    Via Business Wire
    Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy
    From Guardant Health, Inc.
    Via Business Wire
    Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
    From Guardant Health, Inc.
    Via Business Wire
    Why Guardant Health Stock Just Crashed 10%
    Via The Motley Fool
    PDD Holdings, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)
    Via AB Newswire
    Exposures COVID-19
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
    Via The Motley Fool
    Guardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield™ Blood Test for Colorectal Cancer Screening
    From Guardant Health, Inc.
    Via Business Wire
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
    Via The Motley Fool
    Cathie Wood's Ark Invest Continues Loads Up On $6.05M Worth Of Robinhood Shares Amid Bitcoin Rebound, Dumps Zoom Stock
    Via Benzinga
    Guardant Health to Participate in Upcoming Investor Conferences
    From Guardant Health, Inc.
    Via Business Wire
    GH Stock Earnings: Guardant Health Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Guardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
    From Guardant Health, Inc.
    Via Business Wire
    Guardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Colorectal Cancer
    From Guardant Health, Inc.
    Via Business Wire
    Why Exact Sciences, Up 20%, Is 'Coiled To Snap Back' After Quarterly Beat
    Via Investor's Business Daily
    Guardant Health’s FDA-approved Shield™ Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer
    From Guardant Health, Inc.
    Via Business Wire
    Guardant Health Outcomes Model Confirms the Public Health Importance of Enhanced Colorectal Cancer Screening Outcomes with High Adherence Strategies
    From Guardant Health, Inc.
    Via Business Wire
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
    Via The Motley Fool
    FDA Greenlights Guardant Health's Shield Blood Test, Analyst Cautious on Adoption
    Via Benzinga
    Exposures Product Safety
    Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening
    From Guardant Health, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.